These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27392417)

  • 1. Direct and Indirect Effects of Heavy Alcohol Use on Clinical Outcomes in a Longitudinal Study of HIV Patients on ART.
    Kahler CW; Liu T; Cioe PA; Bryant V; Pinkston MM; Kojic EM; Onen N; Baker JV; Hammer J; Brooks JT; Patel P
    AIDS Behav; 2017 Jul; 21(7):1825-1835. PubMed ID: 27392417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol consumption patterns and HIV viral suppression among persons receiving HIV care in Florida: an observational study.
    Cook RL; Zhou Z; Kelso-Chichetto NE; Janelle J; Morano JP; Somboonwit C; Carter W; Ibanez GE; Ennis N; Cook CL; Cohen RA; Brumback B; Bryant K
    Addict Sci Clin Pract; 2017 Sep; 12(1):22. PubMed ID: 28950912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol use accelerates HIV disease progression.
    Baum MK; Rafie C; Lai S; Sales S; Page JB; Campa A
    AIDS Res Hum Retroviruses; 2010 May; 26(5):511-8. PubMed ID: 20455765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and drinking behaviour of patients on antiretroviral therapy who drink and attend HIV clinics in Tshwane, South Africa: Implications for intervention.
    Parry CD; Londani M; Shuper PA; Myers B; Kekwaletswe CT; Nkosi S; Morojele NK
    S Afr Med J; 2019 Sep; 109(10):784-791. PubMed ID: 31635577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to On-Time ART Drug Pick-Up and Its Association with CD4 Changes and Clinical Outcomes Amongst HIV Infected Adults on First-Line Antiretroviral Therapy in Nigerian Hospitals.
    Anoje C; Agu KA; Oladele EA; Badru T; Adedokun O; Oqua D; Khamofu H; Adebayo O; Torpey K; Chabikuli ON
    AIDS Behav; 2017 Feb; 21(2):386-392. PubMed ID: 27388161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hazardous alcohol consumption is not associated with CD4+ T-cell count decline among PLHIV in Kampala Uganda: A prospective cohort study.
    Wandera B; Tumwesigye NM; Nankabirwa JI; Kambugu AD; Mafigiri DK; Kapiga S; Sethi AK
    PLoS One; 2017; 12(6):e0180015. PubMed ID: 28665974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between cigarette smoking, virologic suppression, and CD4+ lymphocyte count in HIV-Infected Russian women.
    Brown JL; Winhusen T; DiClemente RJ; Sales JM; Rose ES; Safonova P; Levina O; Belyakov N; Rassokhin VV
    AIDS Care; 2017 Sep; 29(9):1102-1106. PubMed ID: 28497980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial.
    Edelman EJ; Moore BA; Holt SR; Hansen N; Kyriakides TC; Virata M; Brown ST; Justice AC; Bryant KJ; Fiellin DA; Fiellin LE
    AIDS Behav; 2019 Jan; 23(1):211-221. PubMed ID: 30073637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
    J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol consumption and HIV disease progression.
    Samet JH; Cheng DM; Libman H; Nunes DP; Alperen JK; Saitz R
    J Acquir Immune Defic Syndr; 2007 Oct; 46(2):194-9. PubMed ID: 17667330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam.
    Cuong DD; Sönnerborg A; Van Tam V; El-Khatib Z; Santacatterina M; Marrone G; Chuc NT; Diwan V; Thorson A; Le NK; An PN; Larsson M
    BMC Infect Dis; 2016 Dec; 16(1):759. PubMed ID: 27986077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol consumption and CD4 T-cell count response among persons initiating antiretroviral therapy.
    Kowalski S; Colantuoni E; Lau B; Keruly J; McCaul ME; Hutton HE; Moore RD; Chander G
    J Acquir Immune Defic Syndr; 2012 Dec; 61(4):455-61. PubMed ID: 22955054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subsidized optimal ART for HIV-positive temporary residents of Australia improves virological outcomes: results from the Australian HIV Observational Database Temporary Residents Access Study.
    Petoumenos K; Watson J; Whittaker B; Hoy J; Smith D; Bastian L; Finlayson R; Sloane A; Wright ST; McManus H; Law MG
    J Int AIDS Soc; 2015; 18(1):19392. PubMed ID: 25680919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral load outcomes in a cohort of alcohol-consuming people living with HIV receiving antiretroviral therapy in Mumbai, India.
    Sarna A; Singh RJ; Schensul JJ; Gaikwad SS; Joshi K; Malye R; Mahapatra B; Ha T; Schensul S
    Int J STD AIDS; 2020 Jul; 31(8):763-772. PubMed ID: 32525465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health literacy, antiretroviral adherence, and HIV-RNA suppression: a longitudinal perspective.
    Paasche-Orlow MK; Cheng DM; Palepu A; Meli S; Faber V; Samet JH
    J Gen Intern Med; 2006 Aug; 21(8):835-40. PubMed ID: 16881943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.